Since 2012, cases of "polio-like" neurological syndromes of uncertain etiology have been reported in the US ([@R1], [@R2]) and other countries ([@R3]). These syndromes, now referred to as acute flaccid myelitis (AFM), are characterized by acute onset of flaccid limb weakness with lesions in spinal cord grey matter ([@R4]). AFM has affected over 500 individuals in the US alone and exhibits predominantly biennial patterns in the US ([@R5]) and internationally ([@R6]). Enterovirus D68 (EV-D68) appears to be the leading cause of AFM, though comprehensive understanding of causality is still incomplete ([@R7]).

EV-D68 is a nonpolio enterovirus, previously associated with primarily respiratory symptoms ([@R8]). It was first discovered in 1962 ([@R9]) and was sporadically reported until 2014, when a large EV-D68 outbreak associated with severe respiratory illnesses occurred in North America; millions of individuals were likely to have been infected in the US during this outbreak, even though only 1,153 cases were confirmed in 49 states ([@R10]). Since then, EV-D68 outbreaks have reoccurred every other year (2014, 2016, and 2018) in the US, coinciding with major AFM outbreaks ([@R11]--[@R13]). Understanding the epidemiological dynamics of EV-D68 is critical for assessing its causal relationship with AFM and potentially predicting the course of AFM outbreaks.

Nonpolio enterovirus surveillance in the US currently relies on passive reporting through the National Enterovirus Surveillance System (NESS) ([@R14]). A recent analysis of the NESS data revealed a large geographical variation in the seasonality of nonpolio enteroviruses and the roles of climatic variables in driving seasonal patterns ([@R15]). However, passive surveillance has several limitations. As enterovirus reports are mostly outbreak-driven, the data are sparse and do not reflect endemic dynamics of enteroviruses; thus only 26 cases of EV-D68 infection were reported between 1970 and 2005 ([@R14]). The current gap in EV-D68 (as well as other nonpolio enterovirus) surveillance limits our ability to investigate epidemiological dynamics of circulation and association with AFM.

Here, we study EV-D68 dynamics using novel surveillance data collected from the BioFire® Syndromic Trends (Trend) network ([@R16]). BioFire Trend provides near real-time surveillance based on deidentified clinical test results using the BioFire® System ([@R16]). EV-D68 cases are then predicted using a Pathogen Extended Resolution (PER) algorithm (see ([@R16]) for details, and [Materials and Methods S1.1](#SD1){ref-type="supplementary-material"} for a summary) from the samples that tested positive for rhinovirus/enterovirus (RV/EV) from the BioFire® FilmArray® Respiratory (RP) Panel results ([@R17]). We analyze PER-predicted EV-D68 cases across 24 states, consisting of 55 sites, in the US between January 2014 and September 2019. We aggregated the data into 14 regions by combining adjacent states such that each region has at least 3 contributing sites to meet the confidentiality requirements. Separate permission was obtained from the sites in Missouri. This unique data set allows us to characterize detailed spatiotemporal patterns of EV-D68 circulation, which otherwise would not have been possible.

[Fig. 1A](#F1){ref-type="fig"} presents time series of weekly proportion of PER-predicted EV-D68 cases (n=9,913) from RV/EV samples (n=165,036) in the US and in 5 regions with the biggest number of RV/EV samples during the study period: New York (NY; n=37,430), Ohio (OH; n=22,448), Missouri (MO; n=11,706), the Utah and Colorado region (UT+CO; n=20,880), and the Florida, Georgia, and South Carolina region (FL+GA+SC; n=21,273). Time series of weekly proportion (as well as number) of PER-predicted EV-D68 cases and weekly number of RV/EV cases for all 14 regions are presented in [Supplementary Materials](#SD1){ref-type="supplementary-material"} [Fig. S1](#SD1){ref-type="supplementary-material"}--[S3](#SD1){ref-type="supplementary-material"}. These time series demonstrate a clear overall biennial pattern in the US, as well as a considerable variation in the PER-predicted EV-D68 dynamics across different regions ([Fig. 1A](#F1){ref-type="fig"}; [Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S1](#SD1){ref-type="supplementary-material"}--[S2](#SD1){ref-type="supplementary-material"}). For example, region-level PER-predicted EV-D68 dynamics exhibit regular biennial (NY and UT+CO), multiennial (MO and OH), and irregular dynamics (FL+GA+SC). These observations are consistent with the results of wavelet analyses ([Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S4](#SD1){ref-type="supplementary-material"}--[S9](#SD1){ref-type="supplementary-material"}; [Materials and Methods S1.4](#SD1){ref-type="supplementary-material"}). The absence of a major outbreak in Ohio, and possibly Missouri, in 2016 ([Fig. 1A](#F1){ref-type="fig"}; cf. ([@R18])) is particularly surprising, given the apparent biennial pattern in the US. Overall, the outbreaks in 2016 appear to be less synchronized, compared to the outbreaks in 2014 and 2018 ([Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S10](#SD1){ref-type="supplementary-material"}).

We characterize the geographical variation in the seasonal patterns of PER-predicted EV-D68 dynamics by calculating the center of gravity (i.e., mean timing of cases ([@R19])) for each region ([Fig. 1B](#F1){ref-type="fig"}; [Materials and Methods S1.5](#SD1){ref-type="supplementary-material"}). The centers of gravity vary from July to November. A bivariate regression analysis of the centers of gravity, using latitude and longitude of the mean state capitals in each region as covariates, suggests a significant, latitudinal increase (0.18 months per degree; 95% CI: 0.11 -- 0.26; *p \<* 0.001; [Fig. 1C](#F1){ref-type="fig"}) and latitudinal decrease in mean timing of cases (−0.020 months per degree; 95% CI: −0.038 -- −0.002; *p \<* 0.05; [Fig. 1D](#F1){ref-type="fig"}). These patterns are consistent with the observed patterns from the analyses of other nonpolio enteroviruses and poliomyelitis based on the NESS data and are likely driven by seasonal climatic trends ([@R15]).

Spatiotemporal association between EV-D68 and AFM {#S1}
=================================================

A visual comparison of monthly time series of the number of confirmed AFM cases and the proportion of PER-predicted EV-D68 cases at the national level suggests a temporal association, albeit with minor differences in their patterns ([Fig. 2A](#F2){ref-type="fig"}). Notably, the peaks of AFM epidemics occur in September, which is one month after the peaks of PER-predicted EV-D68 epidemics ([Fig. 2A](#F2){ref-type="fig"}). The pairwise cross-correlation between the two time series supports this observation -- the strongest correlation occurs at a one-month lag ([Fig. 2B](#F2){ref-type="fig"}). This correlation is significant (*r* = 0.7; *p \<* 0.001; [Fig. 2C](#F2){ref-type="fig"}).

A one-month lag is longer than the observed delay between onset of prodromal respiratory symptoms and AFM from clinical studies; the estimated median delays range from 2 to 8 days across studies ([@R20]--[@R24]). Our estimated lag is likely to be caused by two approximations. First, the AFM data are reported at a monthly scale, meaning that delays smaller than one month are difficult to assess. Second, there are variations in AFM reporting, which reflects differential awareness and its passive nature ([@R25]), as well as differential deployment of the BioFire® System (see [Supplementary Text S2.1](#SD1){ref-type="supplementary-material"}). Given state-level variations in the temporal patterns of EV-D68 circulation ([Fig. 1A](#F1){ref-type="fig"}), comparing the national AFM cases with the PER-predicted EV-D68 cases from 18 states is likely to exaggerate the differences.

The proportions of PER-predicted EV-D68 cases in 2014, 2016 and 2018 remain roughly constant ([Fig. 2A](#F2){ref-type="fig"}), whereas the number of confirmed AFM cases in 2018 (*n* = 238) nearly doubled compared to that in 2014 (*n* = 120). Although this pattern is likely to reflect increased surveillance efforts and awareness of AFM ([@R25]), other factors could have played a role. For example, phylogenetic analyses of recent EV-D68 outbreaks have demonstrated the spread of different lineages in different years ([@R26]). Although it remains unclear whether neurotropism is a recently acquired trait ([@R27], [@R28]), some studies have suggested that a subset of contemporary EV-D68 strains are more neurovirulent than the prototypical 1962 strain ([@R27],[@R29]). Future studies may consider whether increased neurovirulence of recent EV-D68 strains is associated with the increased number of AFM cases. Geographically isolated sporadic AFM outbreaks associated with other nonpolio enteroviruses (e.g., enterovirus A71 outbreak in 2018 Colorado ([@R30])) could have contributed to the increased number of AFM cases in certain areas.

We find strong (though noisy), positive correlations between the annual number of confirmed AFM cases and the proportion of PER-predicted EV-D68 cases in most regions ([Fig. 2D](#F2){ref-type="fig"}; [Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S11](#SD1){ref-type="supplementary-material"}--[13](#SD1){ref-type="supplementary-material"}). We use a permutation test to quantify the significance of the average of these correlations (*r* = 0.51; 95% CI: 0.33--0.69; *p \<* 0.001). A linear mixed effects analysis with random intercepts and slopes across regions further supports the positive temporal association between AFM and PER-predicted EV-D68 dynamics (*p \<* 0.001; [Fig. 2E](#F2){ref-type="fig"}; [Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S12](#SD1){ref-type="supplementary-material"}). Even though there is a large regional variation in the PER-predicted EV-D68 dynamics ([Fig. 1](#F1){ref-type="fig"}; [Fig. S1](#SD1){ref-type="supplementary-material"}--[S2](#SD1){ref-type="supplementary-material"}) and the observed AFM dynamics ([Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S13](#SD1){ref-type="supplementary-material"}), we find clear biennial patterns in both across all four census regions (except for the PER-predicted EV-D68 dynamics in the Midwest; [Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S14](#SD1){ref-type="supplementary-material"}). These results indicate that the biennial association between EV-D68 and AFM is robust across the US.

Epidemiological model fitting {#S2}
=============================

We use an epidemiological model to test whether an interaction between prolonged, serotype-specific immunity and an increase in the susceptible pool via birth (post maternal immunity) can explain the state-level variation in the observed EV-D68 dynamics. Pons-Salort and Grassly ([@R31]) showed that the acquisition of serotype-specific immunity can explain complex dynamics observed in other nonpolio enterovirus surveillance data from Japan: in general, large outbreaks reduce the number of susceptible individuals significantly and will be followed by a series of small outbreaks until a sufficient number of susceptible individuals have been added to the population through birth. Like them, we use a stochastic Susceptible-Infected-Recovered (SIR) model that assumes homogeneous mixing, seasonally varying transmission rates, and realistic birth and death rates ([Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S15](#SD1){ref-type="supplementary-material"}; [Materials and Methods S1.2](#SD1){ref-type="supplementary-material"}). We find maximum likelihood estimates (MLE) of model parameters by fitting the model to time series of proportion of PER-predicted EV-D68 cases between January 2014 and December 2017 from the 4 regions that we presented earlier ([Fig. 1](#F1){ref-type="fig"}); we do not fit the model to the Florida, Georgia, and South Carolina region because two epidemic peaks in 2016 come from different states, which cannot be captured by our model. Fitting the model to data from other regions are precluded by the sparsity of PER-predicted EV-D68 cases. We then assess whether our SIR model can accurately predict out-of-sample EV-D68 dynamics by projecting model fits until September 2019. All confidence intervals are calculated by importance sampling ([@R32]). A detailed explanation of the methods is given in [Materials and Methods S1.6](#SD1){ref-type="supplementary-material"}--[S1.7](#SD1){ref-type="supplementary-material"}.

Our simple, mechanistic model can capture the PER-predicted EV-D68 dynamics from 2014 to 2017 in all 4 regions ([Fig. 3A](#F3){ref-type="fig"}). Our model fits also demonstrate that the observed regional variations in EV-D68 dynamics are consistent with model parameter variations; however, some of these variations may be caused by the brevity and crudeness of the time series, as well as the simplicity of the model (see [Discussion](#S3){ref-type="sec"}), and may not reflect real differences among states. All parameter estimates are presented in [Supplementary Materials](#SD1){ref-type="supplementary-material"} [Fig. S16](#SD1){ref-type="supplementary-material"}--[S20](#SD1){ref-type="supplementary-material"} and [Table S2](#SD1){ref-type="supplementary-material"}--[S5](#SD1){ref-type="supplementary-material"}.

We estimate similar ranges of time-varying effective reproductive number $\mathcal{R}_{t}$ (i.e., the average number of secondary cases caused by an infected individual over the course of an epidemic ([@R33])) between 2014 and 2017 for all 4 regions ([Supplementary Materials](#SD1){ref-type="supplementary-material"}, [Fig. S21](#SD1){ref-type="supplementary-material"}): New York (0.6--1.4), Ohio (0.3--1.3), Missouri (0.6--1.5), and the Utah and Colorado region (0.8--1.3). However, there is a large variation in the estimates of the basic reproductive number $\mathcal{R}_{0}$ (i.e., the average number of secondary cases caused by an infected individual in a fully susceptible population): New York (29.5; 95% CI: 26.8--32.7), Ohio (10.7; 95% CI: 8.4--13.0), Missouri (20.6; 95% CI: 17.0--27.7) and the Utah and Colorado region (14.6; 95% CI: 10.9--18.5). Since epidemiological dynamics of endemic diseases, such as EV-D68, are driven by $\mathcal{R}_{t}$, high estimates of $\mathcal{R}_{0}$ are likely to be correlated with low estimates of *S*(0). Not explicitly accounting for age structure, metapopulation structure, and heterogeneity in the population is also likely to have affected our estimates ([@R34]).

Predicting future EV-D68 dynamics from a short time series is difficult. Our model predicts EV-D68 outbreaks in the Utah and Colorado region and in Missouri reasonably well but imperfectly in Ohio and New York. While the model predicts a large outbreak New York in 2018 ([Fig. 3A](#F3){ref-type="fig"}), the observed outbreak in 2018 occurred later in the year and was smaller than the outbreaks in 2014 and 2016. This mismatch suggests that the observed pattern of EV-D68 spread in 2018 New York may be different from the biennial outbreaks observed in 2014 and 2016.

We tested whether our simple model can explain the patterns in 2018 by fitting the same model to the New York and Ohio time series, including the outbreak in 2018. We find that our model can then explain the apparent changes in the EV-D68 dynamics in 2018 reasonably well ([Fig. 3B](#F3){ref-type="fig"}). However, the new model fit does not necessarily provide better predictions for the dynamics in 2019; this lack of fit is partly driven by anomalies in the data (e.g., the PER algorithm predicts almost no EV-D68 cases in Ohio and in the Utah and Colorado region in 2019).

Including the outbreaks from New York and Ohio in 2018 into our model fitting yields much closer estimates of $\mathcal{R}_{0}$: New York (17.0; 95% CI: 15.9 -- 19.7) and Ohio (14.8; 95% CI: 13.8 -- 16.5). These changes in the estimated basic reproductive number can suggest a transition in the long-term dynamics to cycles of different periodicity ([@R35]). While both parameter sets give *qualitatively* similar fits to 2014--2017 time series, the initial parameter estimate provides a *quantitatively* better fit for the first 4 years (a difference of 17 and 21 log-likelihood units for New York and Ohio, respectively); these differences confirm that our initial parameter estimates are well-identified. Given the brevity of the time series, it is not surprising that there are multiple parameter combinations that give qualitatively similar short-term dynamics but different long-term dynamics.

Finally, we explore the long-term stability of the EV-D68 attractors using a bifurcation diagram of the deterministic SIR model ([Fig. 4A](#F4){ref-type="fig"}; [Materials and Methods S1.8](#SD1){ref-type="supplementary-material"}). We rely on estimated parameters for New York, since it has the best available data for EV-D68. The bifurcation diagram predicts predominantly annual cycles in Ohio (excluding 2018) and the Utah and Colorado region although multiple attractors may coexist (indicated by the fine-grained pattern of colors representing different cycle periods; cf. ([@R35])); dynamical transitions due to stochasticity may drive irregular patterns in these regions. Our model predicts a stable, long-term biennial cycle in New York (excluding 2018) and Missouri, but their parameters lie near the edge of a dynamical transition that divides the biennial regime from irregular (New York) and annual (Missouri) regimes. On the other hand, parameter estimates that include the 2018 outbreaks in New York and Ohio are closer together and are within an annual regime, suggesting that the patterns observed in 2014--2017 might have been a transient feature. Although these results suggest that the observed biennial pattern may not be stable in the long term, stochastic simulations show that a moderate to large outbreak, comparable to that in 2014, is possible between August and September 2020 across the ranges of parameters we estimate for New York if epidemiological conditions remain unchanged ([Fig. 4B](#F4){ref-type="fig"}).

In practice, massive non-pharmaceutical (social distancing) efforts in response to the ongoing COVID-19 pandemic could reduce average contact rates during 2020 ([@R36]). We explore the potential impact of these actions on EV-D68 dynamics in [Fig. 4C](#F4){ref-type="fig"}--[E](#F4){ref-type="fig"}. If average transmission rate is reduced by more than 10%, a major EV-D68 outbreak is unlikely to occur. Note that we do not explore longer term dynamics, arising from the consequent increase in EV-D68 susceptibility.

Discussion {#S3}
==========

Here, we present the first spatiotemporal analysis of EV-D68 dynamics in the US and its population correlation with cases of AFM. Our analysis reveals spatial variation in the patterns of spread of EV-D68. We showed that these variations are correlated with latitude and longitude and can be explained by a simple SIR model at the state level. These observations are consistent with previous studies of enteroviruses and are likely climate-driven ([@R15], [@R31]). Finally, our analyses suggest that the predominant medium-term biennial dynamics in the spread of EV-D68 may not necessarily be stable. Given uncertainties in EV-D68 dynamics as well as in behavioral changes due to the COVID-19 pandemic, the occurrence or the size of EV-D68 outbreaks in 2020 remains unclear.

There is currently a lack of data to characterize more detailed epidemiological dynamics of EV-D68. Even though EV-D68 has been circulating for at least 60 years ([@R9]), our data from the PER algorithm, which predicts the presence of EV-d68, only span the last 6 years. The passive surveillance data is expected to be even sparser. Based on such short time series, it is difficult to assess whether the observed patterns will persist. Nonetheless, our simple model captures the observed dynamics reasonably well and allows us to make useful predictions about the course of the epidemic; these predictions will become firmer as more data becomes available. More broadly, this analysis underlines the power of leveraging novel sources of large-sample surveillance data ([@R37]). While the BioFire Trend data permit a step change in analysis, surveillance based on constant sampling effort would be much more powerful. Population-representative incidence and serological data by state (as well as internationally) would allow us to further characterize the dynamics of EV-D68 and its association with AFM.

An important criterion for probing the causality between EV-D68 and AFM is their temporality at the individual level (i.e., infection of EV-D68 has to precede the onset of neurological symptoms ([@R7])), which is supported by the observed onset of respiratory illnesses ([@R38]) and the detection of EV-D68 ([@R39],[@R40]) prior to the onset of AFM. Our cross-scale comparison of EV-D68 and AFM dynamics revealed robust correlations between the timing of EV-D68 and AFM cases, providing additional ecological support for a causal link.

Our dynamic model relied on several simplifying assumptions about the biology of EV-D68. For example, we assumed that the infectious period distribution follows an exponential distribution with a mean of 7 days. Although Pons-Salort and Grassly ([@R31]) showed that nonpolio enterovirus dynamics in Japan can be explained sufficiently well under the same assumption, assumptions about the shape of the infectious period distribution can affect model dynamics ([@R41], [@R42]) as well as $\mathcal{R}_{0}$ estimates ([@R43]). More importantly, ignoring potential uncertainties in model parameters (e.g., assuming that the mean infectious period is known) can underestimate the overall uncertainties associated with the conclusion ([@R44]). We also did not test for other mechanisms (e.g., changes in pathogenicity, antigenicity or transmissibility ([@R31]) or interactions with other nonpolio enteroviruses ([@R45])) that could account for the apparent change in epidemiological dynamics in New York in 2018. Future phylodynamics models ([@R46]) should explore integrated epidemiological and viral genetic dynamics. We also did not account for age structure, strength of immunity, and spatial coupling between states; these simplifications are likely to have affected our estimates of the basic reproductive number. Predictions about the stability of the biennial cycles should be interpreted with caution as our analysis relies on short time series. Our preliminary analysis of the impact of the coronavirus pandemic is necessarily crude. For instance, SARS-CoV-2 and EV-D68 are likely to have very different mean ages of transmission. Nonetheless, current behavioral changes are profound across ages; significant impact of EV-D68 dynamics seems likely.

Despite the simplicity of the analysis, we can draw robust conclusions about key aspects of EV-D68 dynamics. First, the PER-predicted EV-D68 dynamics are consistent with the importance of transmission-blocking herd immunity. Second, although our estimates of the $\mathcal{R}_{0}$ are necessarily approximate, they are likely to be relatively high (\> 10). This is consistent with a low median age of infection for EV-D68 (5 years ([@R47])) as well as $\mathcal{R}_{0}$ estimates for other nonpolio enteroviruses exhibiting biennial cycles in Japan (e.g., $\mathcal{R}_{0} = 16.2$ for Coxsackievirus A2 and $\mathcal{R}_{0} = 32.7$ Coxsackievirus A4 ([@R31])). The successful SIR model fits also imply that vaccination could tentatively control the spread of EV-D68, but herd immunity thresholds are likely to be high ([@R31]).

Although there is large uncertainty associated with the stability of the observed biennial pattern, we predict that a major EV-D68 outbreak can occur in the near future. Based on the low number of PER-predicted EV-D68 cases in 2019, we would expect the number of susceptible individuals to have increased, enhancing the probability for a large outbreak to occur. Our preliminary analysis indicates that the COVID-19 pandemic response may significantly impact the dynamics of a 2020 EV-D68 outbreak; if social distancing prevents the outbreak from occurring, the susceptible pool may increase even further. There are several such potential impacts of pandemic social distancing on other infections; predicting these effects and testing such models against the actuality will be a powerful test of the effects of contact reduction. We propose that mainly 'ecological' interactions, such as between SARS-CoV-2 and EV-D68 ([@R48]), will generate weaker effects than interactions mediated by acquired immunity with SARS-CoV-2's close relatives, which affect the susceptible pool ([@R49]).

Improved real-time surveillance, such as the BioFire Trend system, may serve as an important early warning system for impending outbreaks and improve epidemiological modeling to better understand and predict future patterns of circulation. As the PER algorithm is likely no longer to function after this year due to a product update, future research should therefore prioritize developing specific, and accurate, demographically and geographically representative testing for EV-D68 and its enteroviral relatives. More generally, current events underline the importance in future of refining global pathogen and immunological surveillance against the range of potential threats.
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![Spatiotemporal dynamics of PER-predicted EV-D68 cases across 24 states (2014--2019).\
(A) Weekly proportion of PER-predicted EV-D68 cases. A clear biennial pattern can be observed in the US time series, but local patterns vary. (B) Map of center of gravity of PER-predicted EV-D68 cases. (C) Latitudinal and (D) longitudinal variation in the center of gravity across 14 regions. Red circles represent 5 regions in panel A. Black circles represent the remaining 9 regions. Areas of the circles (and a triangle) are proportional to the number of RV/EV samples. Solid lines represent the estimated regression lines and the associated 95% CIs from the bivariate linear regression; since the bivariate regression depend on two continuous variables, the estimated univariate relationships are plotted by fixing the remaining covariate at its average values.](nihpp-2020.07.23.20069468-f0001){#F1}

![Comparisons of PER-predicted EV-D68 cases and reported AFM cases.\
(A) Monthly time series of proportion of PER-predicted EV-D68 cases (black bars) and confirmed AFM cases (red lines) in the US. AFM reports are not available prior to August 2014. (B) Pairwise cross-correlation plot between the two monthly time series at the national level using all available EV-D68 and AFM data. (C) Comparison between the monthly proportion of PER-predicted EV-D68 cases at a one month lag and the monthly number of AFM cases at the national level. The solid line is estimated from a linear regression. (D) Map of correlations between annual proportion of PER-predicted EV-D68 cases and the number of AFM cases between 2014--2019 showing a positive association between the two. (E) Comparison between the annual proportion of PER-predicted EV-D68 cases and the annual number of AFM cases across 14 regions (represented by different shapes for each region). Black line represents the estimated fixed effects from a linear mixed model with random slopes and intercepts. Red lines represents the estimated line for each region from a linear mixed model. All correlations are measured after stabilizing time series variances ([Materials and Methods S1.3](#SD1){ref-type="supplementary-material"}). The axes in Panel C and E are transformed to reflect the variance stabilization.](nihpp-2020.07.23.20069468-f0002){#F2}

![Model fit to data for New York, Ohio, Missouri.\
(A) A comparison of the PER-predicted (red lines) and model-predicted (grey lines) weekly proportion of positive cases. Predictions were made by simulating forward from 10 particle filtered trajectories. (B) A comparison of the PER-predicted and model-predicted weekly proportion of positive cases, including the outbreak in 2018 into our parameter estimation procedure.](nihpp-2020.07.23.20069468-f0003){#F3}

![Long- and short-term predictions of EV-D68 dynamics.\
A. Bifurcation diagram of the deterministic SIR model using parameter estimates for New York but by varying $\mathcal{R}_{0}$ and the relative amplitude of the seasonal forcing. Colors indicate the mean periodicity of the cycles. Circles represent the original parameter estimates for each state. The triangle and diamond represent the new parameter estimates that include the 2018 outbreak for New York and Ohio, respectively. B--E. Predictions of EV-D68 outbreak in 2020 using stochastic simulations using parameter estimates for New York (B) and assuming 5% (C), 10% (D), and 20% (E) decrease in transmission rates from the 12th week of 2020 until the end of 2020. For each $\mathcal{R}_{0}$ value, we let $S(0) = 1.04/\mathcal{R}_{0}$ and run 100 stochastic simulations until December 2020. We calculate the normalized incidence by dividing the medians of the model-predicted weekly incidence by the median of the model-predicted peak incidence in 2014.](nihpp-2020.07.23.20069468-f0004){#F4}
